3D Bioprinting Market Report by Component (3D Bioprinters, Scaffolds, Biomaterials), Application (Research, Clinical), End User (Hospitals, Research Organization and Academic Institutes, Biopharmaceuticals Companies), and Region 2024-2032

3D Bioprinting Market Report by Component (3D Bioprinters, Scaffolds, Biomaterials), Application (Research, Clinical), End User (Hospitals, Research Organization and Academic Institutes, Biopharmaceuticals Companies), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A4556
Buy Now

Market Overview:

The global 3D bioprinting market size reached US$ 1,205.8 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 4,281.9 Million by 2032, exhibiting a growth rate (CAGR) of 14.7% during 2024-2032. The growing geriatric population, increasing focus on research and development (R&D) activities, and less disrupted market represent some of the key factors driving the market.

Report Attribute
 Key Statistics 
Base Year
2023
Forecast Years
2024-2032
Historical Years
2018-2023
Market Size in 2023
US$ 1,205.8 Million
Market Forecast in 2032
US$ 4,281.9 Million
Market Growth Rate 2024-2032 14.7%


Rising Geriatric Population Augmenting Market Growth

The rising geriatric population currently represents one of the primary factors driving the 3D bioprinting market. There is an increase in the demand for organ transplantation among the geriatric population, as they are more prone to chronic diseases. Moreover, the wide availability of various medical technologies and the presence of competent specialists in the industry is supporting the growth of the market.

Global 3D Bioprinting Market

Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. The market structure is moderately fragmented with the presence of numerous regional and global players in the industry. The volume of new entrants is moderate in the 3D bioprinting industry due to the high capital investments and excessive entry and exit barriers. Moreover, the product differentiation is moderate in the industry due to little differentiation between several manufacturers.

What is 3D Bioprinting?

Three-dimensional (3D) bioprinting refers to an additive manufacturing method designed for the development of precise anatomical tissues. It comprises various deposition and assembling processes, such as direct and laser writing, microstamping, photolithography, stereolithography, electro-printing, and inkjet deposition. It relies on the decomposition of cell-based bio-inks that are manufactured using living cells, biomaterials, and active biomolecules to create 3D structures of tissues and organs. It deposits multiple layers of biomaterials to build numerous complex bodily structures, such as bones, skin, cartilage, vascular grafts, tracheal splints, and heart tissues. As a result, 3D bioprinting is widely utilized in hospitals, research organizations, academic institutes, and biopharmaceutical companies across the globe.

COVID-19 Impact:

The COVID-19 pandemic outbreak caused severe problems for various industries and imposed unprecedented challenges on numerous countries. But 3D bioprinting has emerged as a vital technology in the healthcare industry during the COVID-19 pandemic. There was an increased demand for 3D bioprinted organs due to the unavailability or shortage of medical products. In addition to this, various companies were using state-of-the-art 3D bioprinting platforms to fabricate SARS-CoV-2-infected human airway and lung organoid models. Moreover, these models were being used to study COVID-19 disease progression and for rapid drug screening. There was an increased utilization of bioprinters on account of the rising COVID-19 cases across the globe. Apart from this, the pandemic has slightly hampered the 3D bioprinting market due to the reduction in the production process. Various key manufacturers were forced to temporarily shut down or pause their production process for the first few months of the pandemic due to the widespread of the virus.

3D Bioprinting Market Trends:

At present, the increasing awareness among consumers to minimize animal testing represents one of the major factors influencing the market positively. Besides this, the growing demand for 3D bioprinting among the geriatric population, as they are more prone to various chronic diseases, is offering a positive market outlook. In addition, various technological advancements, such as the development of organ-on-a-chip, is propelling the growth of the market. Apart from this, the increasing demand for regenerative medicines, cancer therapeutics, and stem cell solutions among the masses around the world is contributing to the growth of the market. Moreover, the rising adoption of 3D bioprinting in the healthcare industry, as it is a less disrupted market, is supporting the growth of the market. Furthermore, key manufacturers are focusing on research and development (R&D) activities to introduce bioprinted tissues to reduce the cost of new innovations and enhance the process of finding new drugs.

 

 
 

 

Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global 3D bioprinting market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on component, application and end user.

Component Insights:

 

 
 

 

Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

  • 3D Bioprinters
    • Syringe/Extrusion Bioprinting
    • Inkjet Bioprinting
    • Magnetic Levitation Bioprinting
    • Laser-assisted Bioprinting
    • Others
  • Scaffolds
  • Biomaterials
    • Living Cells
    • Hydrogels
    • Extracellular Matrices
    • Others
       

The report has provided a detailed breakup and analysis of the 3D bioprinting market based on the component. This includes 3D bioprinters (syringe or extrusion bioprinting, inkjet bioprinting, magnetic levitation bioprinting, laser-assisted bioprinting, and others), scaffolds, and biomaterials (living cells, hydrogels, extracellular matrices, and others). According to the report, 3D bioprinters (syringe or extrusion bioprinting, inkjet bioprinting, magnetic levitation bioprinting, laser-assisted bioprinting, and others) represented the largest segment due to the increasing utilization of syringe or extrusion-based bioprinting technology in printing various biological compounds or devices. In addition to this, the rising awareness among individuals about the 3D bioprinters technology is bolstering the growth of the market.

Application Insights:

  • Research
    • Drug Research
    • Regenerative Medicine
    • 3D Cell Culture
  • Clinical
    • Skin
    • Bone and Cartilage
    • Blood Vessels
    • Others
       

A detailed breakup and analysis of the 3D bioprinting market based on the application has also been provided in the report. This includes research (drug research, regenerative medicine, and 3D cell culture) and clinical (skin, bone and cartilage, blood vessels, and others). According to the report, research (drug research, regenerative medicine, and 3D cell culture) accounted for the largest market share, as 3D printing technology is widely utilized among researchers to study the effects of different diseases and their progression and possible treatments. Moreover, it reduces the need to use lab animals for medical tests and dangerous trials on humans.

End User Insights:

  • Hospitals
  • Research Organization and Academic Institutes
  • Biopharmaceuticals Companies
     

A detailed breakup and analysis of the 3D bioprinting market based on the end user has also been provided in the report. This includes hospitals, research organization and academic institutes, and biopharmaceuticals companies. According to the report, biopharmaceuticals companies accounted for the largest market share due to the increasing number of target therapies. In addition, the rising collaborations and mergers among biopharmaceutical companies to develop 3D bioprinting is positively influencing the market.

Regional Insights:

 

 
 

 

To get more information on the regional analysis of this market, Request Sample

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for 3D bioprinting. Some of the factors driving the North America 3D bioprinting market included the growing prevalence of various chronic diseases, presence of key players, and increasing private and government investment. Moreover, the introduction of laser bio-printing method that can make live 3D printed bio-tissues to create artificial tissues is positively influencing the market.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global 3D bioprinting market. Some of the companies covered in the report include:

  • 3D Systems Inc.
  • Aspect Biosystems Ltd.
  • Cellink
  • Cyfuse Biomedical K.K.
  • EnvisionTEC GmbH (Desktop Metal Inc.)
  • GeSiM – Gesellschaft für Silizium-Mikrosysteme mbH
  • Materialise
  • Organovo Holdings Inc.
  • Poietis
  • RegenHU
  • Stratasys Ltd.
     

Please note that this only represents a partial list of companies, and the complete list has been provided in the report.

Report Coverage:

Report Features Details
Base Year of the Analysis 2023
Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Million
Segment Coverage Component, Application, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered 3D Systems Inc., Aspect Biosystems Ltd., Cellink, Cyfuse Biomedical K.K., EnvisionTEC GmbH (Desktop Metal Inc.), GeSiM – Gesellschaft für Silizium-Mikrosysteme mbH, Materialise, Organovo Holdings Inc., Poietis, RegenHU and Stratasys Ltd.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Key Benefits for Stakeholders:

  • IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the 3D bioprinting market from 2018-2032.
  • The research study provides the latest information on the market drivers, challenges, and opportunities in the global 3D bioprinting market.
  • The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
  • Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the 3D bioprinting industry and its attractiveness.
  • Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.

Key Questions Answered in This Report

The global 3D bioprinting market was valued at US$ 1,205.8 Million in 2023.

We expect the global 3D bioprinting market to exhibit a CAGR of 14.7% during 2024-2032.

The increasing application of 3D bioprinting for liver modeling and development of medical implants, is currently catalyzing the global 3D bioprinting market.

The sudden outbreak of the COVID-19 pandemic has led to the rising use for 3D bioprinting as a rapid fabrication method for designing and producing preventive, diagnostic, and treatment devices to combat the spread of coronavirus infection.

Based on the component, the global 3D bioprinting market can be segmented into 3D bioprinters, scaffolds, and biomaterials. Among these, 3D bioprinters, including syringe/extrusion bioprinting currently holds the majority of the total market share.

Based on the application, the global 3D bioprinting market has been divided into research and clinical. Currently, research exhibits a clear dominance in the market.

Based on the end user, the global 3D bioprinting market can be categorized into hospitals, research organization and academic institutes, and biopharmaceuticals companies. Among these, biopharmaceuticals companies currently account for the largest market share.

On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.

Some of the major players in the global 3D bioprinting market include 3D Systems Inc., Aspect Biosystems Ltd., Cellink, Cyfuse Biomedical K.K., EnvisionTEC GmbH (Desktop Metal Inc.), GeSiM – Gesellschaft für Silizium-Mikrosysteme mbH, Materialise, Organovo Holdings Inc., Poietis, RegenHU, and Stratasys Ltd.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
3D Bioprinting Market Report by Component (3D Bioprinters, Scaffolds, Biomaterials), Application (Research, Clinical), End User (Hospitals, Research Organization and Academic Institutes, Biopharmaceuticals Companies), and Region 2024-2032
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More